NYSE - Nasdaq Real Time Price
USD
Novo Nordisk A/S (NVO)
38.85
+0.56
(+1.45%)
As of 12:31:27 PM EDT. Market Open.
Trade NVO on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutNovo Nordisk faces intensified competition after Eli Lilly reported stronger phase-three retatrutide results against Ozempic. Citi retained a neutral/high-risk ratingand a DKK296 target price, while Novo is preparing new liver-disease data and expanding its diabetes portfolio. NVO is up 1.45% in current regular-session trading on October 29, 2026.
